Involvement of CYR61 and CTGF in the fascin-mediated proliferation and invasiveness of esophageal squamous cell carcinomas cells

American Journal of Pathology

Volumn 176, Issue 2, 2010, Pages 939-951

  Xie, Jian Jun ^a   Xu, Li Yan ^a   Wu, Jian Yi ^a   Shen, Zhong Ying ^a   Zhao, Qing ^a   Du, Ze Peng ^a   Lv, Zhuo ^a   Gu, Wei ^a   Pan, Feng ^a   Xu, Xiu E ^a   Xie, Dong ^a,b   Li, En Min ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b Chinese Academy of Sciences   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CONNECTIVE TISSUE GROWTH FACTOR; CYSTEINE RICH PROTEIN 61; FASCIN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; CARCINOMA CELL; CELL IMMORTALIZATION; CELL INVASION; CELL PROLIFERATION; DOWN REGULATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STAINING; SURVIVAL; UPREGULATION; WESTERN BLOTTING;

EID: 76149087797     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090118     Document Type: Article

References (43)

1. Mariette C, Balon JM, Piessen G, Fabre S, Van Seuningen I, Triboulet JP: Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer 2003, 97:1616-1623
2. Law SY, Fok M, Cheng SW, Wong J: A comparison of outcome after resection for squamous cell carcinomas and adenocarcinomas of the esophagus and cardia. Surg Gynecol Obstet 1992, 175:107-112
3. Wang LS, Chow KC, Wu CW: Expression and up-regulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate. Br J Cancer 1999, 80:1617-1622
4. Ding Y, Shimada Y, Gorrin-Rivas MJ, Itami A, Li Z, Hong T, Maeda M, Komoto I, Kawabe A, Kaganoi J, Imamura M: Clinicopathological significance of human macrophage metalloelastase expression in esophageal squamous cell carcinoma. Oncology 2002, 63:378-384
5. Adams JC: Formation of stable microspikes containing actin and the 55 kDa actin bundling protein, fascin, is a consequence of cell adhesion to thrombospondin-1: implications for the anti-adhesive activities of thrombospondin-1. J Cell Sci 1995, 108:1977-1990
6. Kureishy N, Sapountzi V, Prag S, Anilkumar N, Adams JC: Fascins, and their roles in cell structure and function. Bioessays 2002, 24:350-361
7. Adams JC: Roles of fascin in cell adhesion and motility. Curr Opin Cell Biol 2004, 16:590-596
8. Jawhari AU, Buda A, Jenkins M, Shehzad K, Sarraf C, Noda M, Farthing MJ, Pignatelli M, Adams JC: Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. Am J Pathol 2003, 162:69-80
9. Hashimoto Y, Shimada Y, Kawamura J, Yamasaki S, Imamura M: The prognostic relevance of fascin expression in human gastric carcinoma. Oncology 2004, 67:262-270
10. Hashimoto Y, Ito T, Inoue H, Okumura T, Tanaka E, Tsunoda S, Higashiyama M, Watanabe G, Imamura M, Shimada Y: Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma. Clin Cancer Res 2005, 11:2597-2605
11. Xie JJ, Xu LY, Zhang HH, Cai WJ, Mai RQ, Xie YM, Yang ZM, Niu YD, Shen ZY, Li EM: Role of fascin in the proliferation and invasiveness of esophageal carcinoma cells. Biochem Biophys Res Commun 2005, 337:355-362
12. Zhang H, Xu L, Xiao D, Xie J, Zeng H, Cai W, Niu Y, Yang Z, Shen Z, Li E: Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma. J Clin Pathol 2006, 59:958-964
13. Brigstock DR: The CCN family: a new stimulus package. J Endocrinol 2003, 178:169-175
14. Zeng H, Xu L, Xiao D, Zhang H, Wu X, Zheng R, Li Q, Niu Y, Shen Z, Li E: Altered expression of ezrin in esophageal squamous cell carcinoma. J Histochem Cytochem 2006, 54:889-896
15. Shen ZY, Xu LY, Li EM, Cai WJ, Shen J, Chen MH, Cen S, Tsao SW, Zeng Y: The multistage process of carcinogenesis in human esophageal epithelial cells induced by human papillomavirus. Oncol Rep 2004, 11:647-654
16. Shimada Y, Imamura M, Wagata T, Yamaguchi N, Tobe T: Characterization of 21 newly established esophageal cancer cell lines. Cancer 1992, 69:277-284
17. Department of Cell Biology of CICAMS: Establishment of a cell line from human esophageal carcinoma. Chin Med J (Engl) 1976, 2:357-364
18. Tong X, Xie D, O'Kelly J, Miller CW, Muller-Tidow C, Koeffler HP: Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer. J Biol Chem 2001, 276:47709-47714
19. Deng YZ, Chen PP, Wang Y, Yin D, Koeffler HP, Li B, Tong XJ, Xie D: Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor/Lef signaling. J Biol Chem 2007, 282:36571-36581
20. Rong J, Xu LY, Cai WJ, Xiong XD, Li JT, Fang WK, Shen ZY, Li EM: Expression of fascin 1 gene in the process of the immortalized esophageal carcinoma carcinogenesis. Ai Zheng 2004, 23:243-248
21. Chen Y, Du XY: Functional properties and intracellular signaling of CCN1/Cyr61. J Cell Biochem 2007, 100:1337-4135
22. Grotendorst GR, Okochi H, Hayashi N: A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ 1996, 7:469-480
23. Leask A, Abraham DJ: All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci 2006, 119:4803-4810
24. Leivonen SK, Kähä ri VM: Tran̈sforming growth factor-beta signaling in cancer invasion and metastasis. Int J Cancer 2007, 121:2119-2124
25. Breitkopf K, Sawitza I, Westhoff JH, Wickert L, Dooley S, Gressner AM: Thrombospondin 1 acts as a strong promoter of transforming growth factor beta effects via two distinct mechanisms in hepatic stellate cells. Gut 2005, 54:673-681
26. Hashimoto Y, Skacel M, Adams JC: Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker? Int J Biochem Cell Biol 2005, 37:1787-1804
27. Jo WS, Mizukami Y, Duerr EM, Zukerberg LR, Chung DC: Wnt signaling can repress thrombospondin-1 expression in colonic tumorigenesis. Cancer Biol Ther 2005, 4:1361-1366
28. Bottone FG, Jr Moon Y, Kim JS, Alston-Mills B, Ishibashi M, Eling TE: The anti-invasive activity of cyclooxygenase inhibitors is regulated by the transcription factor ATF3. Mol Cancer Ther 2005, 4:693-703
29. Khan K, Hardy R, Haq A, Ogunbiyi O, Morton D, Chidgey M: Desmocollin switching in colorectal cancer. Br J Cancer 2006, 95:1367-1370
30. Xie D, Nakachi K, Wang H, Elashoff R, Koeffler HP: Elevated levels of connective tissue growth factor. WISP-1, and CYR61 in primary breast cancers associated with more advanced features Cancer Res 2001, 61:8917-8923
31. Gery S, Xie D, Yin D, Gabra H, Miller C, Wang H, Scott D, Yi WS, Popoviciu ML, Said JW, Koeffler HP: Ovarian carcinomas: cCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells. Clin Cancer Res 2005, 11:7243-7254
32. Jiang WG, Watkins G, Fodstad O, Douglas-Jones A, Mokbel K, Mansel RE: Differential expression of the CCN family members Cyr61. CTGF and Nov in human breast cancer. Endocr Relat Cancer 2004, 11:781-791
33. Labbé E, Lock L, Letamendia A, Gorska AE, Gryfe R, Gallinger S, Moses HL, Attisano L: Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis. Cancer Res 2007, 67:75-84
34. Pardali K, Moustakas A: Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta 2007, 1775:21-62
35. Rees JR, Onwuegbusi BA, Save VE, Alderson D, Fitzgerald RC: In vivo and in vitro evidence for transforming growth factor-beta1-mediated epithelial to mesenchymal transition in esophageal adenocarcinoma. Cancer Res 2006, 66:9583-9590
36. Von Rahden BH, Stein HJ, Feith M, Pühringer F, Theisen J, Siewert JR, Sarbia M: Overexpression of TGF-beta1 in esophageal (Barrett's) adenocarcinoma is associated with advanced stage of disease and poor prognosis. Mol Carcinog 2006, 45:786-794
37. Miller AV, Alvarez SE, Spiegel S, Lebman DA: Sphingosine kinases and sphingosine-1-phosphate are critical for transforming growth factor beta-induced extracellular signal-regulated kinase 1 and 2 activation and promotion of migration and invasion of esophageal cancer cells. Mol Cell Biol 2008, 28:4142-4151
38. Sargiannidou I, Zhou J, Tuszynski GP: The role of thrombospondin-1 in tumor progression. Exp Biol Med 2001, 226:726-733
39. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, Hynes RO, Boivin GP, Bouck N: Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 1998, 93:1159-1170
40. Annes JP, Munger JS, Rifkin DB: Making sense of latent TGF beta activation. J Cell Sci 2003, 116:217-224
41. Rojas A, Meherem S, Kim YH, Washington MK, Willis JE, Markowitz SD, Grady WM: The aberrant methylation of TSP1 suppresses TGF-beta1 activation in colorectal cancer. Int J Cancer 2008, 123:14-21
42. Adams JC: Characterization of cell-matrix adhesion requirements for the formation of fascin microspikes. Mol Biol Cell 1997, 8: 2345-2363
43. Adams JC, Schwartz MA: Stimulation of fascin spikes by thrombospondin-1 is mediated by the GTPases Rac and Cdc42. J Cell Biol 2000, 150:807-822